In July, the Department of Health launched a review of the problem, after the House of Commons All-Party Group on Drug Misuse called for greater awareness, better doctor training and more treatment options. Although medical guidelines discourage doctors from prescribing benzodiazepine tranquilizers such as Valium for more than four weeks at a time, many patients still become addicted.
Who is Patrick McGorry and what does he promote? He’s a psychiatrist just named Australian of the Year for his work in “youth mental health reform.” What does that reform consist of? What he calls a “new form of climate change.” It sure is. He not only promotes youths being put on antipsychotics and antidepressants, cited by international drug regulatory agencies as causing hallucinations, hostility, personality change, life-threatening diabetes, strokes, suicide and death, McGorry goes a giant step further—drug them before they’ve even developed a “psychiatric” disorder. The Association for the Accreditation of Human Research Protection Programs (AHRPP) likens such concepts to “performing mastectomies on women who are at risk of—but do not have—breast cancer.”
In this paper I want to review the investigations from the Citizens Committee for Human Rights in Mental Health. It is this organisation in the United States and other countries that have consistently brought the dangers of psychiatry to the attention of the general public who by and large are the victims of a marriage between pharmaceutical companies and their paid distributors of lethal drugs, psychiatrists. This alliance has been based on the greed for money, profits and kudos all in the name of a science that as one leading authority called – “hokum”
The multi-billion dollar drug company, Johnson & Johnson (J&J), has come under fire for allegedly violating the rules in their marketing of Risperdal, an antipsychotic drug. Back in 1999, the Food and Drug Administration (FDA) told J&J that their marketing materials for geriatric patients overstated Risperdals benefits and minimized risks, according to Bloomberg.com. In 2000, an internal business plan strategized a way to increase Risperdals market share by marketing the benefits for elderly dementia, an unapproved use.
Women expecting a baby have been warned over taking Prozac while they are pregnant, after a new study found it could be harmful to an unborn child. According to a study from the Medicines and Healthcare Products Regulatory Agency there is a “small risk” of babies developing heart problems should their mother take the drug early on in their pregnancy.
SHARE YOUR STORY/COMMENT: